Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin

BACKGROUND AND PURPOSE: In randomized trials, atrial fibrillation (AF) patients receiving dabigatran, a direct oral anticoagulant, had lower risk of intracranial bleeding (ICB) than those on warfarin. However, concerns exist about potential worse outcomes in dabigatran users if bleeding occurs, give...

Full description

Saved in:
Bibliographic Details
Main Authors: Alonso, Alvaro, Bengtson, Lindsay, MacLehose, Richard, Lutsey, Pamela L., Chen, Lin Yee, Lakshminarayan, Kamakshi
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116615/
https://ncbi.nlm.nih.gov/pubmed/24994722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.114.006016
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items